How Did ALS Limited (ASX:ALQ) Lift FY26 Revenue to AUD 3.32 Billion?

Aditi Sarkar

28 October 2026 09:04 PM AEDT

How Did ALS Limited (ASX:ALQ) Lift FY26 Revenue to AUD 3.32 Billion?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

FY26 Revenue rose 10.7% to AUD 3.32 billion, including 8.4% organic growth.
Underlying EBIT increased 19.3% to AUD 599.0 million and underlying NPAT reached AUD 381.2 million.
Minerals organic revenue increased 20.2%, with its underlying EBIT Margin reaching 33.0%.

ALS Limited (ASX:ALQ) was trading at AUD 20.15, up 0.80% at the 27 October 2026 close. The company’s reported results and operating disclosures cover the financial performance, Business activities and other corporate measures described below.

Revenue and Earnings across the group

For the year ended 31 March 2026, ALS reported revenue of AUD 3,320.1 million against AUD 2,999.4 million in FY25. The company attributed AUD 250.0 million of the increase to organic growth, AUD 12.9 million to changes in scope and AUD 57.8 million to currency movements. Underlying EBIT reached AUD 599.0 million, an increase of 19.3%, and the underlying EBIT margin expanded by 129 basis points to 18.0%. Underlying net profit after tax rose 25.8% to AUD 381.2 million. Statutory net profit after tax totalled AUD 318.7 million, up 24.4%.

Commodities testing and mineral activity

ALS reported Minerals organic revenue growth of 20.2% and a Minerals underlying EBIT margin of 33.0%, up 250 basis points. The company described increased sample flows across its key regions, alongside an improvement in pricing and the mix of work received. It said exploration activity from junior Mining companies began to strengthen in the second half, while major and mid-tier customers continued to provide sample flows. Industrial Materials also recorded double-digit organic growth, including a 17.4% increase in Coal.

Life Sciences and other operating measures

Within Life Sciences, Food testing generated 7.2% organic revenue growth, while Environmental delivered 2.8%. ALS reported softer Environmental activity in Latin America and the United States during the second half. Life Sciences margins increased 55 basis points to 14.6%, supported by Food and Pharmaceutical operations. Group free Cash Flow generated reached AUD 674.1 million, an increase of AUD 83.5 million, and underlying EBITDA cash conversion was 92.2%. The company reported a Leverage Ratio of 1.5 times and a full-year Dividend of 42.5 cents per share.

Laboratory Investment and disclosed priorities

The FY26 presentation outlined continued investment in laboratory digitalisation, artificial intelligence and smart-lab efficiency initiatives. Management also discussed wider mine-site production testing services and the network of testing laboratories used to serve mining and industrial clients. These initiatives were presented as part of the company’s operating programme, rather than as achieved financial outcomes. The company stated that several financial targets originally set for FY27 had been delivered in FY26.

FAQs

Q: What was ALS FY26 revenue?

A: AUD 3.32 billion, up 10.7%.

Q: How much underlying EBIT did ALS report?

A: AUD 599.0 million, up 19.3%.

Q: What was the Minerals margin?

A: 33.0%, an increase of 250 basis points.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.